Back to top

AbbVie (ABBV) Gets a Buy from Barclays

Barclays analyst Carter Gould maintained a Buy rating on AbbVie (ABBV – Research Report) today and set a price target of $195.00. The company’s sha...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AbbVie Inc. (ABBV)